picotamide has been researched along with Thrombocythemia, Essential in 1 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Thrombocythemia, Essential: A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders." | 1.29 | Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. ( Carpi, A; Ferretti, A; Nicolini, A; Sagripanti, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagripanti, A | 1 |
| Ferretti, A | 1 |
| Nicolini, A | 1 |
| Carpi, A | 1 |
1 other study available for picotamide and Thrombocythemia, Essential
| Article | Year |
|---|---|
Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Hemorrhage; | 1996 |